iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024
iSpecimen Inc. (ISPC) will report its financial results for the full year ended December 31, 2023, before the market opens on March 13, 2024. A conference call and webcast featuring remarks by CEO Tracy Curley will follow at 8:30 a.m. Eastern Time.
03/05/2024 - 04:30 PM
LEXINGTON, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”) , an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the full year ended December 31, 2023 before the market opens on Wednesday, March 13, 2024.
The Company will host a conference call and audio webcast that morning at 8:30 a.m. Eastern Time featuring remarks by Tracy Curley, CEO.
For interested individuals unable to join the conference call, a replay will be available through March 27, 2024, at +1-844-512-2921 (U.S. Toll Free) or +1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 37478374. An archived version of the webcast will also be available on iSpecimen’s Investor Relations site: https://investors.ispecimen.com/presentations/ .
About iSpecimen www.ispecimen.com .
Forward Looking Statements
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are characterized by future or conditional verbs such as “may,” “will,” “expect,” “intend,” “anticipate,” believe,” “estimate” and “continue” or similar words. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information.
Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to the risks factors contained in the Company’s filings with the Securities and Exchange Commission, which are available for review at www.sec.gov . Forward-looking statements speak only as of the date they are made. New risks and uncertainties arise over time, and it is not possible for the Company to predict those events or how they may affect the Company. If a change to the events and circumstances reflected in the Company’s forward-looking statements occurs, the Company’s business, financial condition and operating results may vary materially from those expressed in the Company’s forward-looking statements.
Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.
For further information, please contact:
Investor Contact iSpecimen@kcsa.com
Media Contacts iSpecimen@kcsa.com
When will iSpecimen Inc. report its financial results for the full year ended December 31, 2023?
iSpecimen Inc. will report its financial results on March 13, 2024.
Who will be hosting the conference call and webcast for iSpecimen Inc.?
The conference call and webcast will feature remarks by CEO Tracy Curley.
What time will the conference call and webcast take place?
The conference call and webcast will take place at 8:30 a.m. Eastern Time.
How can interested individuals access the replay of the conference call?
Interested individuals can access the replay through March 27, 2024, at the provided phone numbers and using the code 37478374.
Where can an archived version of the webcast be found?
An archived version of the webcast will be available on iSpecimen’s Investor Relations site.
ISPC Rankings
N/A Ranked by Stock Gains
ISPC Stock Data
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Sector
Professional, Scientific, and Technical Services
About ISPC
headquartered in lexington, ma, ispecimen is the marketplace for human biospecimens, providing researchers with the specimens they need from the patients they want. the privately held company has developed the ispecimen marketplace, an online platform connecting healthcare organizations that have access to patients and specimens with the scientists who need them. proprietary, cloud-based technology enables researchers to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. researchers easily and compliantly gain access to specimens to drive scientific discovery. partner sites gain an opportunity to contribute to biomedical discovery as well as their bottom line. and ultimately, healthcare advances for all.
